Found 5 matching trials
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
PHASE3The purpose of this study is to assess the safety and efficacy of golimumab...
Location
Multiple Locations
Golimumab (GLM) Dose Optimisation to Adequate Levels to Achieve Response in Colitis
PHASE4GLM dose Optimisation to Adequate Levels to Achieve Response in Colitis (GO...
Location
St Vincent's University Hospital
The Incidence of Extra-Articular Manifestations in Participants With Ankylosing Spondylitis Treated With Golimumab (MK-8259-012)
PHASE4The objective of this study is to determine the difference in the annual in...
Location
Multiple Locations
Golimumab (MK-8259 / SCH900259) Treatment Withdrawal in Participants With Non-radiographic Axial Spondyloarthritis (GO-BACK) (MK-8259-038)
PHASE4The purpose of this study is to evaluate the effect of treatment withdrawal...
Location
FN Brno ( Site 0005)
Subcutaneous Golimumab (GLM) Plus DMARDs for Rheumatoid Arthritis, Followed by Intravenous/Subcutaneous GLM Strategy (P06129 AM2)
PHASE3Part 1 of this trial will assess the safety and effectiveness of subcutaneo...
Location
Multiple Locations